Immunotherapy Program

 

Drabick JJ, Schell TD. Poking CD40 for cancer therapy, another example of the Goldilocks effect. Cancer Biol and Therapy 2010; Nov; 10(10): 994-6. Epub 2010 Nov 15

 

Fateh S, Schell TD, Gingrich R, Neves RI, Drabick JJ. Unsuccessful High Dose IL-2 Therapy Followed Immediately by Low Dose Metronomic Temozolomide Results in Rapid Durable Complete and near-Complete Remissions in Metastatic Melanoma. Cancer Biology Ther 2010; Dec 1: 10(11) 1091-7. Epub 2010 Dec 1

 

Fulchiero GJ, Salvagio H, Drabick JJ, Stavely-O'Carroll K, Billingsley EM, Marks EM, Helm KF. Eruptive latent metastatic melanomas after initiation of anti-tumor necrosis factor therapies.  J Amer Acad Derm 2007; 56(5 Suppl): S65-7

 

Drabick JJ, Glasspool-Malone J, Somiari S, King A, Malone RW.  Increased Efficiency of Cutaneous Transfection and Polynucleotide Immunization Using Invivo Electropermeabilization  Molec Ther  2001; 3(2): 249-55

 

More by colleagues – Schell, Claxton, Christensen, George, Isom